Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Azithromycin 1,5%/Loteprednol 0,5% Eye Drops Versus Individual Administration of Azithromycin 1,5% and Loteprednol 0,5% in the Treatment of Ocular Inflammation and Infection

NCT01721694 is registered in ClinicalTrials.gov with Adapt Produtos Oftalmológicos Ltda. as lead sponsor.

NCT NCT01721694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01721694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Azithromycin 1,5%/Loteprednol 0,5% Eye Drops Versus Individual Administration of Azithromycin 1,5% and Loteprednol 0,5% in the Treatment of Ocular Inflammation and Infection
Lead sponsor
Adapt Produtos Oftalmológicos Ltda.
Phase
Phase 3
Overall status
Withdrawn
Start date
December 31, 2012
Completion date
May 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

conjunctivitis, bacterial, infection associated blepharitis, keratitis, ocular inflammation